Penile cancer
Therapeutic area
Oncology
Rare disease
Yes
- Definition
- A primary or metastatic malignant neoplasm that affects the penis. Representative examples include penile carcinoma and penile sarcoma.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- Yes
- Listing at source
- Listed
- Condition name
- Penile cancer
- Therapeutic area
- Oncology
- penile cancer
- penile neoplasm
- cancer of penis
- malignant neoplasm of penis
- malignant neoplasm of the penis
- malignant penile neoplasm
- malignant penile tumor
- malignant penile tumour
- malignant penis neoplasm
- malignant tumor of penis
- malignant tumor of the penis
- malignant tumour of penis
- malignant tumour of the penis
- penile cancer
- penis cancer
- Severity
- Severe
- Oncology
- Reproductive Health
- MONDO ID
- MONDO:0001325
- Parent condition
- MONDO:0005836
Related records
Broader conditions (16)
- Cancer
- Cancer or benign tumor
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Human disease
- Male reproductive organ cancer
- Male reproductive system disorder
- Male reproductive system neoplasm
- Neoplasm
- Neoplastic disease or syndrome
- Penile disorder
- Penile neoplasm
- Reproductive system cancer
- Reproductive system disorder
- Reproductive system neoplasm
Narrower conditions (16)
- Basaloid carcinoma of the penis
- Glans penis cancer
- Human papillomavirus-related penile squamous cell carcinoma
- Non-invasive verrucous carcinoma of the penis
- Paget disease of the penis
- Papillary carcinoma of the penis
- Penile carcinoma
- Penile sarcoma
- Penile urethral cancer
- Penis basal cell carcinoma
- Penis carcinoma in situ
- Penis mixed squamous cell carcinoma
- Penis verrucous carcinoma
- Sarcomatoid penile squamous cell carcinoma
- Squamous cell carcinoma of penis
- Warty carcinoma of the penis
Trials (57)
- A Chatbot Intervention for Reducing HPV Vaccine Hesitancy
- A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination
- A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
- A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
- A PHASE II, RANDOMIZED STUDY TO ASSESS MAINTENANCE THERAPY WITH CEMIPLIMAB VERSUS BEST SUPPORTIVE CARE AFTER 1ST LINE PLATINUM-BASED CHEMOTHERAPY IN ADVANCED/RECURRENT PENILE CANCER
- A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males
- A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy
- A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Cancer
- Assessment of Patient Experience and Needs for Patients Undergoing Invasive Inguinal Lymph Node Procedures for Penile Cancer
- Cancer in Patients With Gabapentin (GPRD)
- CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas
- Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
- DEfeating PEnile CAncer-2
- Development of Diagnostics and Treatment of Urological Cancers
- E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
- E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- Education, Immigration and HPV Vaccination: an Informational Randomized Trial
- Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations
- Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma (ORPHEUS)
- EGFR-ADC (Becotatug Vedotin) Combined With PD-1 Inhibitor (Pucotenlimab) in Neoadjuvant Treatment of Advanced Penile Cancer
Drugs in development (12)
- Bintrafusp alfa Phase 1
- Cemiplimab Phase 2
- Cisplatin Phase 2
- Docetaxel Phase 2
- Entinostat Phase 1
- Ifosfamide Phase 2
- Immunocytokine nhs-IL12 Phase 1
- Irinotecan hydrochloride Phase 2
- Nimotuzumab Phase 2
- Paclitaxel Phase 2
- Retifanlimab Phase 2
- Toripalimab Phase 2